Principal Investigator
Jun Liu, MD
Ruijin Hospital
Total Trials
1
As PI
1
Completed
0
h-index
N/A
Publications
0
Years Active
0
Research Impact
h-index
N/A
Research impact score
Publications
0
Total publications
Trial Results
0
Published trial results
Citations
0
Total citations
Drug Portfolio
GENETIC(1)
1 unique interventions1 categories
Analytics
Trial Phases
Phase 11
Trial Status
Recruiting1
Role Distribution
Principal Investigator1
PI Rate100%
Activity Timeline
Clinical Trials (1)
A Clinical Study to Evaluate the Safety, and Tolerability of BBM-P002 in the Treatment of Parkinson's Disease
PD
PrincipalinvestigatorStart date: 2025-12-27
Research Network
Collaboration Network
2 collaborators·1 connections
Network Legend
KOL
Current InvestigatorCO
High-influence CollaboratorCO
CollaboratorClick: view details
Double-click: go to profile
Drag: move node
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Ruijin Hospital
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
6 similar investigators found
Frazzitta Giuseppe, MD
"Moriggia-Pelascini" Hospital
1 trials
Shared therapeutic areas:
PD
Similarity Score30%
Dae Joong Kim
Samsung Medical Center
2 trials
Shared therapeutic areas:
PD
Similarity Score30%
Jeff Silverstein, MD
Icahn School of Medicine at Mount Sinai
2 trials
Shared therapeutic areas:
PD
Similarity Score30%
Cay Anderson-Hanley, PhD
iPACES LLC
2 trials
Shared therapeutic areas:
PD
Similarity Score30%
Bob Gillen, PhD
iPACES LLC
1 trials
Shared therapeutic areas:
PD
Similarity Score30%
Jing Sun, MD
Ruijin Hospital
1 trials
Shared therapeutic areas:
PD
Worked with same sponsors:
Shanghai Xinzhi BioMed Co., Ltd.
Collaborated on 1 trial
Similarity Score14%
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
A Clinical Study to Evaluate the Safety, and Tolerability of BBM-P002 in the Treatment of Parkinson's Disease
PD
All 1 trials loaded